COVID-19 Update: Two more Calgary schools alert parents to cases of COVID-19 | Mask wearing in Calgary surged to near 90% after bylaw

Article content continued

The infections in the two camps that house a total of around 120,000 refugees were the first confirmed cases since the pandemic was first reported in the kingdom last March.

Read more.


Saturday

Police in Quebec can issue fines to those refusing to wear masks when obligatory

People gather at a park in Montreal, Quebec, Canada, on Wednesday, May 20, 2020. Quebec has 60% of all virus deaths -- and about two-thirds of those are in the Montreal region. Photographer: Christinne Muschi/Bloomberg ORG XMIT: 775514366
People gather at a park in Montreal, Quebec, Canada, on Wednesday, May 20, 2020. Photo by Christinne Muschi/Bloomberg

Quebecers could face hefty fines starting Saturday if they aren’t wearing a mask in places the province has deemed it mandatory due to COVID-19.

Police will be able to hand out tickets ranging between $400 and $6,000 for those who don’t have a face covering in indoor public spaces or public transit.

The province announced its intention to introduce fines earlier this week, with a ministerial decree being adopted Friday.

The decree specifies that a face covering is understood as a “mask or tightly fitting cloth that covers the nose and the mouth.”

Read more.


Saturday

AstraZeneca resumes UK trials of COVID vaccine halted by patient illness

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.

The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout.

“On 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,” AstraZeneca said.

View Source